LeonaBio, Inc.
LONA
$7.04
-$0.98-12.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 81.16% | 31.47% | -39.23% | -46.53% | -38.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 164.41% | 90.26% | -32.69% | -73.04% | -73.99% |
| Operating Income | -164.41% | -90.26% | 32.69% | 73.04% | 73.99% |
| Income Before Tax | -172.85% | -260.36% | -452.48% | 77.00% | 74.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -172.85% | -260.36% | -452.48% | 77.00% | 74.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -172.85% | -260.36% | -452.48% | 77.00% | 74.06% |
| EBIT | -164.41% | -90.26% | 32.69% | 73.04% | 73.99% |
| EBITDA | -170.30% | -92.75% | 33.21% | 73.74% | 74.63% |
| EPS Basic | 55.04% | 26.06% | -300.02% | 77.53% | 74.54% |
| Normalized Basic EPS | 55.04% | 26.00% | 28.37% | 73.77% | 74.54% |
| EPS Diluted | 55.04% | 26.06% | -300.02% | 77.53% | 74.54% |
| Normalized Diluted EPS | 55.04% | 26.00% | 28.37% | 73.77% | 74.54% |
| Average Basic Shares Outstanding | 506.92% | 387.35% | 38.11% | 2.39% | 1.86% |
| Average Diluted Shares Outstanding | 506.92% | 387.35% | 38.11% | 2.39% | 1.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |